Compare EQH & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | EQH | COCH |
|---|---|---|
| Founded | 1859 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Blank Checks |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 24.4M |
| IPO Year | N/A | N/A |
| Metric | EQH | COCH |
|---|---|---|
| Price | $48.38 | $0.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $64.18 | $9.50 |
| AVG Volume (30 Days) | ★ 2.7M | 448.5K |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,224,000,000.00 | $208,000.00 |
| Revenue This Year | $25.11 | N/A |
| Revenue Next Year | $5.01 | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.38 | N/A |
| 52 Week Low | $41.39 | $0.64 |
| 52 Week High | $56.61 | $2.25 |
| Indicator | EQH | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 50.34 |
| Support Level | $45.42 | $0.80 |
| Resistance Level | $46.17 | $0.86 |
| Average True Range (ATR) | 1.03 | 0.05 |
| MACD | 0.51 | 0.01 |
| Stochastic Oscillator | 80.22 | 59.29 |
Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.